Company intelligence / Profile preview

SinoFresh HealthCare, Inc.

Englewood, Florida, United Statessec.gov ↗

Ownership: Private
Development stage: Commercial

Overview

SinoFresh HealthCare developed and marketed an over-the-counter nasal spray designed to kill germs and remove irritants from the nasal passages. The product demonstrated strong in vitro efficacy against MRSA bacteria and showed promise against H1N1 influenza virus in animal studies. The company pursued FDA approval for a prescription version but primarily sold its OTC product through major U.S. retailers. There are no recent clinical results or regulatory milestones reported after early 2010s.[5][8]

Therapeutic areas: Infectious Diseases
Modalities: Antiseptic nasal sprays (topical antiseptics)
Industry: Biotech

Drug pipeline

1 asset

SinoFresh

Unknown

Partnerships

No major pharmaceutical partnerships disclosed; some academic collaborations noted.

Beyond the preview

Go deeper on SinoFresh HealthCare, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SinoFresh HealthCare, Inc..

Explore the full profile